Latest News & Features
Americas
The biopharma industry must do its part in changing the public's view of the sector, because the political reality is that it is unpopular, according to Brent Saunders, chairman, president and CEO of Allergan. 20 June 2017
Americas
Pharmaceutical company Orexo has filed a complaint against Actavis Elizabeth and Teva Pharmaceuticals for infringing its patents covering Zubsolv. 20 June 2017
Asia
Genome editing company Intellia Therapeutics has been granted a patent from China’s State Intellectual Property Office covering the CRISPR/Cas9 technology. 20 June 2017
Big Pharma
The EU’s General Court will this month hear three competition cases involving generic companies, with the first—brought by Slovenian business Krka—being heard today. 20 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s ruling in a dispute over diagnostic tests for cardiovascular diseases. 19 June 2017
Americas
Johnson & Johnson Innovation, the division that focuses on forming collaborations between entrepreneurs and J&J’s healthcare businesses, has announced a series of new collaborations. 16 June 2017
Asia-Pacific
Merck has been granted its first CRISPR technology patent by the Australian Patent Office. 16 June 2017
Americas
The Patent Trial and Appeal Board is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto. 15 June 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a decision by the Patent Trial and Appeal Board (PTAB) which found that two patent applications by Purdue Pharma were unpatentable. 15 June 2017
Africa
The Competition Commission of South Africa has launched an investigation into suspected excessive pricing of cancer medicines by pharmaceutical companies Roche, Pfizer and Aspen Pharmacare. 14 June 2017